Asymmetric azidohydroxylation of styrene derivatives mediated by a biomimetic styrene monooxygenase enzymatic cascade

Journal Article (2021)
Author(s)

Lía Martínez-Montero (TU Delft - BT/Biocatalysis)

Dirk Tischler (Ruhr-Universität Bochum)

Philipp Süss (Enzymicals AG)

Anett Schallmey (Technical University of Braunschweig)

Maurice C.R. Franssen (Wageningen University & Research)

Frank Hollmann (TU Delft - BT/Biocatalysis)

Caroline E. Paul (TU Delft - BT/Biocatalysis)

Research Group
BT/Biocatalysis
Copyright
© 2021 L. Martinez Montero, Dirk Tischler, Philipp Süss, Anett Schallmey, Maurice C.R. Franssen, F. Hollmann, C.E. Paul
DOI related publication
https://doi.org/10.1039/d1cy00855b
More Info
expand_more
Publication Year
2021
Language
English
Copyright
© 2021 L. Martinez Montero, Dirk Tischler, Philipp Süss, Anett Schallmey, Maurice C.R. Franssen, F. Hollmann, C.E. Paul
Research Group
BT/Biocatalysis
Issue number
15
Volume number
11
Pages (from-to)
5077-5085
Reuse Rights

Other than for strictly personal use, it is not permitted to download, forward or distribute the text or part of it, without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license such as Creative Commons.

Abstract

Enantioenriched azido alcohols are precursors for valuable chiral aziridines and 1,2-amino alcohols, however their chiral substituted analogues are difficult to access. We established a cascade for the asymmetric azidohydroxylation of styrene derivatives leading to chiral substituted 1,2-azido alcohols via enzymatic asymmetric epoxidation, followed by regioselective azidolysis, affording the azido alcohols with up to two contiguous stereogenic centers. A newly isolated two-component flavoprotein styrene monooxygenase StyA proved to be highly selective for epoxidation with a nicotinamide coenzyme biomimetic as a practical reductant. Coupled with azide as a nucleophile for regioselective ring opening, this chemo-enzymatic cascade produced highly enantioenriched aromatic α-azido alcohols with up to >99% conversion. A bi-enzymatic counterpart with halohydrin dehalogenase-catalyzed azidolysis afforded the alternative β-azido alcohol isomers with up to 94% diastereomeric excess. We anticipate our biocatalytic cascade to be a starting point for more practical production of these chiral compounds with two-component flavoprotein monooxygenases.